Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Teva pharmaceutical industries ltd crawled date : 2022 - 02 - 11 save search
Regeneron Presents Encouraging Phase 2 Results for High-dose Aflibercept 8 mg in Wet Age-related Macular Degeneration at Angiogenesis Meeting
Published: 2022-02-11 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
phase 2 phase 2 results results macular
Erectile Dysfunction Drugs Market size worth $ 2952 Million, Globally, by 2028 at -3.4% CAGR: Verified Market Research®
Published: 2022-02-11 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
research 2 million drug
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
DV | News | $29.43 -2.36% 0.24% 1.9M
|
Information
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
JEF 4 | $42.17 1.57% 0.07% 1.8M
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.